Use in Geriatric: MAXILIV INJECTION should be used with caution in elderly patients (aged 70 years and above)
According to clinical studies PT-141 Peptide exerts its mechanism of action primarily by targeting melanocortin receptors in the brain
Thus, despite the limitations of rat studies, the results showed that treatment with BPC 157 led to the recovery of tail function and the resolution of spasticity and improved the neurologic recovery
doi: 10.1073/pnas.2332818100
Arsenic exerts its toxicity by binding to the sulfhydryl group of proteins and enzymes, acting as a substrate for phosphorus in metabolic reactions, disrupting oxidative phosphorylation, and inhibiting and degrading mitochondrial enzymes (Ajees et al
913,914 Non-heme iron content in muscle increases with age, and age-related or disuse-induced muscle atrophy are associated with disrupted iron homeostasis and elevated oxidative stress